Combo_Solicitation_Synop5.pdf

COMBINED SYNOPSIS/SOLICITATION:

Clinical Chemistry Reagents and Analyzers

(i) This is a combined synopsis/solicitation (“combo”) for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued.

(ii) Solicitation FA5000-17-T-0005 is issued as a Request for Quotation (RFQ).

(iii) A statement that the solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-95, effective 19 Jan 2017. The DFARS provisions and clauses are those in effect to DPN 20161222, effective 22 Dec 2016. The AFFARS provisions and clauses are those in effect to AFAC 2017-0127, effective 27 Jan 2017.

(iv) This requirement is solicited under ‘Full and Open, unrestricted’ competition. The North American

Industrial Classification System (NAICS) code associated with this procurement is 334516, which has a small business size standard of 1,000 employees.

(v) The Pricing Schedule is incorporated as Attachment 1. Vendors shall complete Attachment 1 in its entirety and return with any other documentation/data as required by this “combo.”

(vi) The government intends to award a firm-fixed price Indefinite Delivery Indefinite/Quantity contract for the following:

For the lease of two Chemical Analyzers with tests as described in Attachment 1 and Attachment 3

(vii) Delivery shall be FOB Destination. Vendor shall include delivery schedule information on the

Pricing Schedule, Attachment 1. All items shall be delivered to:

Joint Base Elmendorf-Richardson, Anchorage Alaska, 99506

(viii) FAR 52.212-1 Instructions to Offerors -- Commercial Items (Jan 2017) is hereby incorporated by reference, with the same force and effect as if it were given in full text. In addition to the following addendum, all terms and conditions of FAR 52.212-1 remain in effect. The following have been tailored to this procurement and are hereby added via addendum:

1. To assure timely and equitable evaluation of the quotation, the vendors shall follow the instructions contained herein. The quotation shall be complete, self-sufficient, and respond directly to the requirements of this solicitation.

2. Specific Instructions: The response shall consist of the following:

a. All quotes shall be emailed to Andrew So at andrew.so@us.af.mil.

b. All vendors shall be registered in the System for Award Management

(www.SAM.gov) database prior to any contract award. Register or renew registration with the Online Representations and Certifications Registration at www.SAM.gov as soon as possible to expedite contract award.

c. The vendor shall submit with each quote a technical acceptability narrative, which shall include a list of each salient characteristic (listed in Attachment 3, Statement of Work, Sections 1 and 2).

file://///FSPIH_NT/regs$/Working/far_doc/FAR12.DOC%23s126 mailto:andrew.so@us.af.mil

d. The vendor shall submit one (1) completed copy of Attachment 1, Pricing Schedule, and one

(1) completed copy of Attachment 2, Pricing Schedule Supplement. In the Pricing Schedule

Supplement, the vendor shall provide how each individual test is packaged (i.e., how many individual tests are in a box or package).

3. Award will be made to the vendor whose quote is conforming to the solicitation and is determined to be the lowest price technically acceptable.

(ix) FAR 52.212-2 Evaluation -- Commercial Items (Oct 2014) this provision has been tailored to this procurement and is provided in full-text below:

(a) The Government will award a contract resulting from this solicitation to the responsible vendor whose quote conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used for evaluation:

(1) Technical

(2) Price

(b) Technical Acceptability Factor: The government will evaluate technical quotes on a pass/fail basis and assign an Acceptable or Unacceptable rating as described in Table 1 below. Technical acceptability shall consist of each analyzer being capable of performing on-board standard chemistry and integrated immunoassay testing with the capabilities detailed in Section 2 of the Statement of Work. In addition, each analyzer shall conform to the requirements detailed in Section 1, paragraphs 1.1 through

1.7 of the Statement of Work in offer in terms of capability of item(s) offered to meet the Government’s need.

(c) Price. The government will rank all quotes by TEP. The price evaluation will document the fairness and reasonableness of the TEP. In addition, each quoter’s separately priced line items shall be analyzed to determine if the prices are unbalanced in accordance with FAR 15.404-1(g). If the quote is found to be technically acceptable, an award will be made without further consideration. If the quote is found to be technically unacceptable, the Government will evaluate the next lowest quote for technical acceptability until an award can be made to the lowest priced technically acceptable quoter.

Table 1. Technical Ratings

Rating Description

Acceptable Quote meets the requirements of the solicitation

Unacceptable Quote does not meet the requirements of the solicitation

(d) A written notice of award or acceptance of a quote mailed or otherwise furnished to the successful vendor within the time for acceptance specified in the quote, shall result in a binding contract without further action by either party. Before the quote’s specified expiration time, the Government may accept a quote (or part of a quote), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.

(End of Provision)

(x) Each vendor shall ensure the provision at FAR 52.212-3 including its Alternate I, Vendors

Representations and Certifications--Commercial Items (Jan 2017), are updated at www.sam.gov. Failure to obtain SAM registration will result in submissions not being considered for award.

(xi) The clause at FAR 52.212-4, Contract Terms and Conditions – Commercial Items (Jan 2017), is hereby incorporated by reference, with the same force and effect as if it were given in full text.

(xii) The clause at FAR 52.212-5, Contract Terms and Conditions Required To Implement Statutes Or

Executive Orders – Commercial Items (Jan 2017), is hereby incorporated by reference, with the same force and effect as if it were given in full text. Additionally, the following clauses apply to this acquisition:

FAR 52.202-1 Definitions Nov 2013

FAR 52.203-3 Gratuities Apr 1984

FAR 52.203-6 Restrictions on Subvendor Sales to the Government Sep 2006

FAR 52.203-6 (Alt 1) Restrictions on Subvendor Sales to the Government Oct 1995

FAR 52.204-7 System for Award Management Oct 2016

FAR 52.204-10 Reporting Executive Compensation and First-Tier Subcontract Awards Oct 2016

FAR 52.204-16 Commercial and Government Entity Code Reporting Jul 2016

FAR 52.204-18 Commercial and Government Entity Code Maintenance Jul 2016

FAR 52.204-19 Incorporation by Reference of Representations and Certifications Dec 2014

FAR 52.209-5 Certification Regarding Responsibility Matters Oct 2015

FAR 52.209-6 Protecting the Government's Interest When Subcontracting with

Vendors Debarred, Suspended, or Proposed for Debarment

Oct 2015

FAR 52.209-7 Information Regarding Responsibility Matters Jul 2013

FAR 52.209-11 Representation by Corporations Regarding Delinquent Tax Liability or a Felony Conviction under any Federal Law

Feb 2016

FAR 52.219-28 Post Award Small Business Program Representation Jul 2013

FAR 52.222-3 Convict Labor Jun 2003

FAR 52-222-19 Child Labor-Cooperation With Authorities and Remedies Oct 2016

FAR 52.222-21 Prohibition of Segregated Facilities Apr 2015

FAR 52.222-26 Equal Opportunity Sep 2016

FAR 52.222-35 Equal Opportunity for Veterans Oct 2015

FAR 52.222-36 Affirmative Action for Workers with Disabilities Jul 2014

FAR 52.222-37 Employment Reports on Veterans Feb 2016

FAR 52.222-40 Notification of Employee Rights Under the National Labor Relations

Act

Dec 2010

FAR 52.222-50 Combating Trafficking in Persons Mar 2015

FAR 52.222-54 Employment Eligibility Verification Oct 2015

FAR 52.223-6 Drug-Free Workplace May 2001

FAR 52.223-18 Encouraging Vendor Policies to Ban Text Messaging While Driving Aug 2011

FAR 52.225-13 Restrictions on Certain Foreign Purchases Jun 2008

FAR 52.225-25 Prohibition on Contracting with Entities Engaging in Certain

Activities or Transactions Relating to Iran—Representation and

Certification

Oct 2015

FAR 52.232-39 Unenforceability of Unauthorized Obligations Jun 2013

FAR 52.232-40 Providing Accelerated Payments to Small Business Subvendors Dec 2013

FAR 52.233-3 Protest after Award Aug 1996

FAR 52.233-4 Applicable Law for Breach of Contract Claim Oct 2004

FAR 52.252-1 Solicitation Provisions Incorporated by Reference Feb 1998

FAR 52.252-2 Clauses Incorporated by Reference Feb 1998

DFARS 252.203-7000 Requirements Relating To Compensation of Former DoD Officials Sep 2011

DFARS 252.203-7002 Requirement to Inform Employees of Whistleblower Rights Sep 2013

DFARS 252-203-7005 Representation Relating to Compensation of Former DoD Officials Nov 2011

DFARS 252.204-7008 Compliance with Safeguarding Covered Defense Information

Controls.

Oct 2016

DFARS 252.204-7011 Alternative Line Item Structure Sep 2011

DFARS 252.204-7012 Safeguarding Covered Defense Information and Cyber Incident

Reporting

Oct 2016

DFARS 252.204-7015 Disclosure of Information to Litigation Support Vendors May 2016

DFARS 252.205-7000 Provision of Information to Cooperative Agreement Holders Dec 1991

DFARS 252.211-7003 Item Unique Identification and Valuation Mar 2016

DFARS 252.222-7007 Representation Regarding Combating Trafficking in Persons Jan 2015

DFARS 252.223-7008 Prohibition of Hexavalent Chromium Jun 2013

DFARS 252.225-7000 Buy American--Balance of Payments Program Certificate Nov 2014

DFARS 252.225-7001 Buy American and Balance of Payments Program Dec 2016

DFARS 252.225-7002 Qualifying Country Sources as Subvendors Dec 2016

DFARS 252.225-7012 Preference for Certain Domestic Commodities Dec 2016

DFARS 252.225-7035 Buy American—Free Trade Agreements—Balance of Payments

Program Certificate

Nov 2014

DFARS 252.225-7035 Alt V Buy American—Free Trade Agreements—Balance of Payments

Program Certificate

Nov 2014

DFARS 252.225-7036 Buy American—Free Trade Agreements—Balance of Payments

Program

Aug 2016

DFARS 252.225-7048 Export-Controlled Items Jun 2013

DFARS 252.226-7001 Utilization of Indian Organizations, Indian-Owned Economic

Enterprises, and Native Hawaiian Small Business Concerns

Sep 2004

DFARS 252.232-7003 Electronic Submission of Payment Requests and Receiving Reports Jun 2012

DFARS 252.232-7006 Wide Area Workflow Payment Instructions May 2013

DFARS 252.232-7010 Levies on Contract Payments Dec 2006

DFARS 252.243-7002 Requests for Equitable Adjustment Dec 2012

DFARS 252.244-7000 Subcontracts for Commercial Items Jun 2013

DFARS 252.247-7023 Transportation of Supplies by Sea--Basic Apr 2014

AFFARS 5352.223-9001 Health and Safety on Government Installations Nov 2012

FAR 52.216-19 – Order Limitations (Oct 1995)

(a) Minimum order. When the Government requires supplies or services covered by this contract in an amount of less than 228 individual tests, the Government is not obligated to purchase, nor is the Vendor obligated to furnish, those supplies or services under the contract.

(b) Maximum order. The Vendor is not obligated to honor --

(1) Any order for a single item in excess of 51,737 individual tests;

(2) Any order for a combination of items in excess of 697,144 tests or TOTAL CONTRACT

VALUE.

(3) A series of orders from the same ordering office within ___10___ days that together call for quantities exceeding the limitation in subparagraph (b)(1) or (2) of this section.

(End of Clause)

FAR 52.216-22 -- Indefinite Quantity (Oct 1995)

(a) This is an indefinite-quantity contract for the supplies or services specified, and effective for the period stated, in the Schedule. The quantities of supplies and services specified in the Schedule are estimates only and are not purchased by this contract.

(b) Delivery or performance shall be made only as authorized by orders issued in accordance with the

Ordering clause. The Contractor shall furnish to the Government, when and if ordered, the supplies or services specified in the Schedule up to and including the quantity designated in the Schedule as the

“maximum.” The Government shall order at least the quantity of supplies or services designated in the

Schedule as the “minimum.”

(c) Except for any limitations on quantities in the Order Limitations clause or in the Schedule, there is no limit on the number of orders that may be issued. The Government may issue orders requiring delivery to multiple destinations or performance at multiple locations.

(d) Any order issued during the effective period of this contract and not completed within that period shall be completed by the Contractor within the time specified in the order. The contract shall govern the

Contractor’s and Government’s rights and obligations with respect to that order to the same extent as if the order were completed during the contract’s effective period; provided, that the Contractor shall not be required to make any deliveries under this contract after _______________ [insert date].

(End of Clause)

DFARS 252.203-7994

PROHIBITION ON CONTRACTING WITH ENTITIES THAT REQUIRE CERTAIN

INTERNAL CONFIDENTIALITY AGREEMENTS—REPRESENTATION (DEVIATION 2017-

O0001)(NOV 2016)

(a) In accordance with Continuing Appropriations Act, 2017 (Pub. L. 114-223), or any other Act that extends to fiscal year 2017 funds the same prohibitions as contained in section 743, division E, title VII, of the Consolidated Appropriations Act, 2016 (Pub. L. 114-113), none of the funds appropriated (or otherwise made available) by this or any other Act may be used for a contract with an entity that requires employees or subvendors of such entity seeking to report fraud, waste, or abuse to sign internal confidentiality agreements or statements prohibiting or otherwise restricting such employees or contactors from lawfully reporting such waste, fraud, or abuse to a designated investigative or law enforcement representative of a Federal department or agency authorized to receive such information.

(b) The prohibition in paragraph (a) of this provision does not contravene requirements applicable to Standard Form 312, Form 4414, or any other form issued by a Federal department or agency governing the nondisclosure of classified information.

(c) Representation. By submission of its offer, the Offeror represents that it does not require employees or subvendors of such entity seeking to report fraud, waste, or abuse to sign or comply with internal confidentiality agreements or statements prohibiting or otherwise restricting such employees or contactors from lawfully reporting such waste, fraud, or abuse to a designated investigative or law enforcement representative of a Federal department or agency authorized to receive such information.

(End of provision)

DFARS 252.203-7995

PROHIBITION ON CONTRACTING WITH ENTITIES THAT REQUIRE CERTAIN

INTERNAL CONFIDENTIALITY AGREEMENTS(DEVIATION 2017-O0001)(NOV 2016)

(a) The Vendor shall not require employees or subvendors seeking to report fraud, waste, or abuse to sign or comply with internal confidentiality agreements or statements prohibiting or otherwise restricting such employees or contactors from lawfully reporting such waste, fraud, or abuse to a designated investigative or law enforcement representative of a Federal department or agency authorized to receive such information.

(b) The Vendor shall notify employees that the prohibitions and restrictions of any internal confidentiality agreements covered by this clause are no longer in effect.

(c) The prohibition in paragraph (a) of this clause does not contravene requirements applicable to

Standard Form 312, Form 4414, or any other form issued by a Federal department or agency governing the nondisclosure of classified information.

(d)(1) Use of funds appropriated (or otherwise made available) by the Continuing Appropriations

Act, 2017 (Pub. L. 114-223), or any other Act that extends to fiscal year 2017 funds the same prohibitions as contained in section 743, division E, title VII, of the Consolidated Appropriations Act, 2016 (Pub. L.

114-113) may be prohibited, if the Government determines that the Vendor is not in compliance with the provisions of this clause.

(2) The Government may seek any available remedies in the event the Vendor fails to perform in accordance with the terms and conditions of the contract as a result of Government action under this clause.

(End of clause)

DFARS 252.209-7991

REPRESENTATION BY CORPORATIONS REGARDING AN UNPAID DELINQUENT TAX

LIABILITY OR A FELONY CONVICTION UNDER ANY FEDERAL LAW—FISCAL YEAR 2016

APPROPRIATIONS (DEVIATION 2016-O0002) (OCT 2015)

(a) In accordance with section 101(a) of the Continuing Appropriations Act, 2016 (Pub. L. 114-53) and any subsequent FY 2016 appropriations act that extends to FY 2016 funds the same restrictions as are contained in sections 744 and 745 of division E, title VII, of the Consolidated and Further Continuing

Appropriations Act, 2015 (Pub. L. 113-235), none of the funds made available by this or any other Act may be used to enter into a contract with any corporation that—

(1) Has any unpaid Federal tax liability that has been assessed, for which all judicial and administrative remedies have been exhausted or have lapsed, and that is not being paid in a timely manner pursuant to an agreement with the authority responsible for collecting the tax liability, where the awarding agency is aware of the unpaid tax liability, unless the agency has considered suspension or debarment of the corporation and made a determination that this further action is not necessary to protect the interests of the Government; or

(2) Was convicted of a felony criminal violation under any Federal law within the preceding 24 months, where the awarding agency is aware of the conviction, unless the agency has considered suspension or debarment of the corporation and made a determination that this action is not necessary to protect the interests of the

Government.

(b) The Offeror represents that—

(1) It is [ ] is not [ ] a corporation that has any unpaid Federal tax liability that has been assessed, for which all judicial and administrative remedies have been exhausted or have lapsed, and that is not being paid in a timely manner pursuant to an agreement with the authority responsible for collecting the tax liability,

(2) It is [ ] is not [ ] a corporation that was convicted of a felony criminal violation under a Federal law within the preceding 24 months.

(End of provision)

DFARS 252.216-7006 – Ordering (May 2011)

(a) Any supplies and services to be furnished under this contract shall be ordered by issuance of delivery orders or task orders by the individuals or activities designated in the contract schedule. Such orders may be issued from __________ through ____________ [insert dates].

(b) All delivery orders or task orders are subject to the terms and conditions of this contract. In the event of conflict between a delivery order or task order and this contract, the contract shall control.

(c)(1) If issued electronically, the order is considered “issued” when a copy has been posted to the

Electronic Document Access system, and notice has been sent to the Vendor.

(2) If mailed or transmitted by facsimile, a delivery order or task order is considered “issued” when the Government deposits the order in the mail or transmits by facsimile. Mailing includes transmittal by U.S. mail or private delivery services.

(3) Orders may be issued orally only if authorized in the schedule.

(End of Clause)

AFFARS 5352.201-9101 – Ombudsman (Apr 2014)

(a) An ombudsman has been appointed to hear and facilitate the resolution of concerns from offerors, potential offerors, and others for this acquisition. When requested, the ombudsman will maintain strict confidentiality as to the source of the concern. The existence of the ombudsman does not affect the authority of the program manager, contracting officer, or source selection official. Further, the ombudsman does not participate in the evaluation of quotations, the source selection process, or the adjudication of protests or formal contract disputes. The ombudsman may refer the interested party to another official who can resolve the concern.

(b) Before consulting with an ombudsman, interested parties shall first address their concerns, issues, disagreements, and/or recommendations to the contracting officer for resolution. Consulting an ombudsman does not alter or postpone the timelines for any other processes (e.g., agency level bid protests, GAO bid protests, requests for debriefings, employee-employer actions, contests of OMB

Circular A-76 competition performance decisions).

(c) If resolution cannot be made by the contracting officer, the interested party may contact the ombudsman, CMSgt James Ting, 25 E. Street, Suite D-306, JBPH-H, HI 96853-5427, Phone: (808) 449-

8569 or email james.Ting@us.af.mil. Concerns, issues, disagreements, and recommendations that cannot be resolved at the Center/MAJCOM/DRU/HQ AFICA/AFISRA/SMC ombudsman level, may be brought by the interested party for further consideration to the Air Force ombudsman, Associate Deputy Assistant

Secretary (ADAS) (Contracting), SAF/AQC, 1060 Air Force Pentagon, Washington DC 20330-1060, phone number (571) 256-2395, facsimile number (571) 256-2431. (INTERIM CHANGE: See Policy

Memo 14-C-05)

(d) The ombudsman has no authority to render a decision that binds the agency.

(e) Do not contact the ombudsman to request copies of the solicitation, verify offer due date, or clarify technical requirements. Such inquiries shall be directed to the Contracting Officer.

(End of clause)

(xii) CONTRACT MINIMUM/MAXIMUM QUANTITY

The minimum quantity for all orders issued against this contract shall not be less than the minimum quantity stated in the following table. The maximum quantity for all orders issued against this contract shall not exceed the maximum quantity stated in the following table.

MINIMUM

QUANTITY

1,832 Tests

MAXIMUM

QUANTITY

3,485,716 Tests

(xiii) NOTICE TO ALL INTERESTED PARTIES:

A site visit will be held at the 673d Medical Group (5955 Zeamer Avenue, JBER, AK 99506) on

Joint Base Elmendorf-Richardson at 2 PM Alaska Time on 24 March 2017. The site is a restricted walk area; so please notify Andrew So, 907-552-7176, no later than 2 PM Alaska Time on 22 March 2017 if the vendor will be present. Nonattendees will still be able to submit a quotation.

Questions shall be submitted to the following personnel:

673d Contracting Squadron/LGCC

Attn: Andrew So, andrew.so@us.af.mil

Please forward all questions to Andrew So, andrew.so@us.af.mil, no later than 10 AM Alaska Standard

Time on 3 April 2017.

Quotes are due no later than 2 PM AKDT on 10 April 2017; quotes shall include the following:

a. Part 1- Technical Acceptability - Submit one (1) copy of technical acceptability narrative as mentioned in paragraph (vii).

b. Part 2- Price – Complete and submit one (1) copy of Attachment 1, Pricing Schedule, and one

(1) copy of Attachment 2, Pricing Schedule Supplement, as well as any additional pertinent information.

(xiv) Quotations shall be submitted to Andrew So, andrew.so@us.af.mil. For information regarding this solicitation, contact the same.

List of Attachments:

Attachment 1: Pricing Schedule (4 pages)

Attachment 2: Pricing Schedule Supplement (3 pages)

Attachment 3: Statement of Work (10 pages)

Attachment 4: CAD Drawing (1 page)

Attachment 1

LINE

ITEM

DESCRIPTION

ORDER

MIN

QTY

(Tests)

†See note below

ORDER

MAX

QTY

(Tests)†

UNIT

OF

ISSUE

UNIT

PRICE

TOTAL

EVALUATED

PRICE (TEP)

(Unit price x Order

Minimum)

Lease of two (2) Chemical

Analyzers to include delivery and installation – 5 year ordering period

All maintenance and software updates are to be provided and to include installation and function testing as well as training and all incidental costs for two personnel at the vendor’s facility.

**See SOW, Attachment 2 for detailed salient characteristics

1 60 Months

Not

Separately

Priced

Not Separately Priced

Acetaminophen

245 2,945 Tests

Automated HDL Cholesterol

1,292 15,501 Tests

Albumin

2,790 33,480 Tests

Ethyl Alcohol

306 3,675 Tests

Automated LDL Cholesterol

259 3,103 Tests

Alkaline Phosphatase

2,214 26,570 Tests

Alanine Aminotransferase

2,228 26,735 Tests

Ammonia

234 2,814 Tests

Amphetamine/methamphetami ne 338 4,062 Tests

Amlyase

333 3,996 Tests

Asparate Aminotransferase

2,219 26,627 Tests

Barbiturate

338 4,062 Tests

Benzodiazepines

338 4,062 Tests

Urea Nitrogen

3,172 38,059 Tests

Calcium

3,177 38,122 Tests

C-Reactive Protein

492 5,910 Tests

CardioPhase High Sensitivity

C-reactive protein 442 5,299 Tests

Cholesterol

1,297 15,569 Tests

Creatine Kinase

423 5,073 Tests

Mass Creatine Kinase MB

Isoenzyme 393 4,714 Tests

Cocaine

338 4,062 Tests

Creatinine

3,185 38,217 Tests

Direct Bilirubin

737 8,840 Tests

Digoxin

230 2,764 Tests

Electrolytes (NA, CL, K)

4,311 51,737 Tests

Enzymatic Carbonate

3,170 38,040 Tests

Ferritin

349 4,193 Tests

Free Triiodothronine

275 3,300 Tests

FreeThyroixne

570 6,836 Tests

Glucose

3,306 39,673 Tests y-Glutamyl Transferase

261 3,138 Tests

Hemoglobin A1C

1,048 12,574 Tests

Human Chorionic

Gonadotropin 584 7,012 Tests

Total Iron Binding Capacity

354 4,254 Tests

Iron

371 4,455 Tests

Lactic Acid

322 3,859 Tests

Lactate Dehydrogenase

314 3,766 Tests

Micro Albumin

510 6,126 Tests

Magnesium

624 7,492 Tests

N-Terminal Pro-Brain

Natriuretic Peptide 321 3,852 Tests

Opiates

338 4,062 Tests

Prealbumin

234 2,808 Tests

Phosphorus

923 11,081 Tests

Phenytoin

228 2,735 Tests

Salicylate

264 3,172 Tests

Total Bilirubin

2,299 27,586 Tests

Triglycerides

1,293 15,513 Tests

Cannabinoids

338 4,062 Tests

Cardiac Tropinin 1

550 6,601 Tests

Total Protein

2,212 26,547 Tests

Total Prostate Specific

Antigen 337 4,047 Tests

Thyroid Stimulating Hormone

1,234 14,803 Tests

Urinary Cerebrospinal Fluid

Protein 232 2,779 Tests

Uric Acid

360 4,325 Tests

Valporic Acid

229 2,748 Tests

Vancomycin

256 3,077 Tests

Lithium

509 6,105 Tests

Estradiol

509 6,105 Tests

Folicle Stimulating Hormone

509 6,105 Tests

Lutenizing Hormone

509 6,105 Tests

Progesterone

509 6,105 Tests

Prolactin

509 6,105 Tests

† For evaluation purposes, the TEP is computed using the price per test, despite how the test is packaged. Upon award, the government will order per the standard packaging identified in

Attachment 2

TOTAL TEP (CLINS 0002 - 0063):

***Shipping costs to JBER, Alaska 99506 SHALL be included within the unit price.***

***Quotes shall be good for a minimum of 60 days from close of solicitation*** Vendors may, at their discretion, provide additional time. THIS QUOTE EXPIRES ON: _________________________

Business Size: - -Owned

Delivery Terms for CLIN 0001 (Mandatory): Net Terms (Mandatory):

*Please attach Delivery Terms for CLINS 0002-0063 (Mandatory)*

DUNS:

Printed Name Title

Signature

Date

NOTE: The individual signing shall be a signatory official for this Entity; signature constitutes agreement to all terms/conditions contained within this solicitation.

LINE

ITEM

DESCRIPTION

PACKAGING METHOD

(Tests/Box)

CONTRACT

MIN QTY

CONTRACT

MAX QTY

Lease of two (2) Chemical

Analyzers to include delivery and installation – 5 year ordering period

N/A 12 60

0002 Acetaminophen 10,769 14,725

0003 Automated HDL Cholesterol 10,387 77,505

0004 Albumin 22,434 167,400

0005 Ethyl Alcohol 2,462 18,374

0006 Automated LDL Cholesterol 2,079 15,513

0007 Alkaline Phosphatase 17,804 132,848

0008 Alanine Aminotransferase 17,915 133,674

0009 Ammonia 1,886 14,069

Amphetamine/methamphetamin e 2,722 20,308

0011 Amlyase 2,678 19,979

0012 Asparate Aminotransferase 17,843 133,137

0013 Barbiturate 2,722 20,308

0014 Benzodiazepines 2,722 20,308

0015 Urea Nitrogen 25,502 190,294

0016 Calcium 25,545 190,609

0017 C-Reactive Protein 3,960 29,549

CardioPhase High Sensitivity

C-reactive protein 3,551 26,493

0019 Cholesterol 10,433 77,847

0020 Creatine Kinase 3,399 25,365

Mass Creatine Kinase MB

Isoenzyme 3,159 23,572

0022 Cocaine 2,722 20,308

0023 Creatinine 25,609 191,086

0024 Direct Bilirubin 5,924 44,202

0025 Digoxin 1,852 13,821

0026 Electrolytes (NA, CL, K) 34,668 258,685

0027 Enzymatic Carbonate 25,490 190,200

0028 Ferritin 2,810 20,966

0029 Free Triiodothronine 2,211 16,500

0030 FreeThyroixne 4,581 34,182

0031 Glucose 26,584 198,366

0032 y-Glutamyl Transferase 2,102 15,688

0033 Hemoglobin A1C 8,426 62,872

Human Chorionic

Gonadotropin 4,699 35,062

0035 Total Iron Binding Capacity 2,850 21,268

0036 Iron 2,985 22,276

0037 Lactic Acid 2,586 19,294

0038 Lactate Dehydrogenase 2,524 18,831

0039 Micro Albumin 4,105 30,630

0040 Magnesium 5,020 37,460

N-Terminal Pro-Brain

Natriuretic Peptide 2,581 19,260

0042 Opiates 2,722 20,308

0043 Prealbumin 1,882 14,042

0044 Phosphorus 7,425 55,404

0045 Phenytoin 1,832 13,673

0046 Salicylate 2,126 15,862

0047 Total Bilirubin 18,485 137,932

0048 Triglycerides 10,395 77,565

0049 Cannabinoids 2,722 20,308

0050 Cardiac Tropinin 1 4,424 33,007

0051 Total Protein 17,789 132,734

0052 Total Prostate Specific Antigen 2,712 20,234

0053 Thyroid Stimulating Hormone 9,919 74,013

Urinary Cerebrospinal Fluid

Protein 1,862 13,895

0055 Uric Acid 2,898 21,624

0056 Valporic Acid 1,841 13,740

0057 Vancomycin 2,062 15,385

0058 Lithium 2,200 30,526

0059 Estradiol 2,200 30,526

0060 Folicle Stimulating Hormone 2,200 30,526

0061 Lutenizing Hormone 2,200 30,526

0062 Progesterone 2,200 30,526

0063 Prolactin 2,200 30,526

JBER, 673d Medical Group Laboratory

STATEMENT OF WORK (SOW)

FOR THE

CHEMISTRY ANALYSIS

JOINT BASE ELMENDORF-RICHARDSON, AK

September 2016

Attachment 3

TABLE OF CONTENTS

SectionTitle Page

1.0 Description of Services 1

2.0 Government and Contractor Furnished 3

Property and Services

3.0 General Information 8

SECTION 1

DESCRIPTION OF SERVICES

1.1.Scope of Work: Multiple chemistry analyzers capable of performing on-board standard chemistry and/or immunoassay chemistry, integrated units. Each analyzer must be adapted for and must meet the specific testing workload and workflow for the Joint Base Elmendorf-Richardson (JBER) 673d Medical Group. The analyzers shall be capable of performing testing with minimal to no manual preparation of samples by technicians and shall perform automated dilutions from original sample tubes. Automatic repeat and reflex testing from the original sample tube is required. The analyzers must be capable of bar code reading and sample level sensing, to include clot and Hemolysis Icteric Lipemia (HIL) detection. The analyzers will accommodate a variety of sample tubes to include primary collection tubes and micro sample tubes. The system will utilize random access sampling to allow for Short Turn-Around Time (STAT) or As Soon As Possible (ASAP) sample loading.

1.2.The analyzers must have automatic pre-analytics to include: sample centrifugation, sample de-capping, sample sorting, sample aliquoting for chemistry with a fixed probe and sample aliquoting for immunoassay by pipetting (to eliminate the need for additional sample carry over studies), and sample distribution to appropriate analytical stations.

1.3.The instrument must have automatic post-analytics with the ability upon completion of testing to: recap samples, sort for appropriate storage, and provide short-term storage that allows for recalling of a sample for add on testing.

1.4.The analyzers must have the capability of auto verification resulting.

1.5.The analyzers must have a “track” type system capable of connecting to future laboratory analyzers. The track system should be able to move samples to designated analytical stations after the required pre-analytical processing.

1.6.The analyzer operating system shall include the capability to track and store, at a minimum, 90 days of calibration, quality control (QC) and patient result data and provide for visual display of graphs and curves for QC data. The analyzer must have the ability to read/write quality control, calibrations, and patient results to DVR for peer group correlation/review purposes. The operating system shall interface with the customer’s laboratory information system (LIS) via RS 232C bidirectional interface and accommodate American Standard Code for Information Interchange (ASCII) query capability to process specimen identification and work orders from the LIS (Laboratory Information System). The operating system must meet the USAF cyber security requirements (i.e. Windows, etc.).

1.7.The analyzers must meet all necessary power, waste and water requirements as dictated by the current laboratory work space. Please see attached CAD drawings for specifics.

1.8.The Contractor shall perform emergency and scheduled maintenance required for optimum operation of the analyzer. Routine contractor maintenance will be scheduled and provided during normal business hours; Monday through Friday 0700 AM-1600 PM local time, for the 673d Medical Group.

SECTION 2

GOVERNMENT AND CONTRACTOR FURNISHED PROPERTY AND SUPPLIES

2. The Contractor will provide:

The 673d Medical Group with two (2) redundant Chemistry Analyzers capable of performing on-board standard chemistry and integrated immunoassay chemistry testing with the following capabilities (to include tests but not limited to):

Anemia: Ferritin.

Cardiac: Mass Creatine Kinase MB Isoenzyme, N-terminal ProBrain Natruiretic Peptide, and Troponin I.

Diabetes: Hemoglobin A1c and Microalbumin

Drugs of Abuse: Amphetamines/Methamphetamine, Barbiturates, Benzodiazepines, Cannabinoids, Cocaine Metabolite, and Opiates.

Electroylytes: Chloride, Potassium, and Sodium.

General Chemistry: Alanine Aminotransferase, Albumin, Alkaline Phosphatase, Ammonia, Amylase, Aspartate Aminotransferase, Calcium, Carbon Dioxide, Cholesterol, Creatinine, Creatine Kinase, Direct Bilirubin, Gamma Glutyl Transaminase, Glucose, HDL Cholesterol, Iron, Lactic Acid, Lactate Dehydrogenase, LDL Cholesterol, Lipase, Magnesium, Phosphorus, Total Bilirubin, Total Iron Binding Capacity, Total Protein, Triglycerides, Urea Nitrogen, Uric Acid, and Urinary/Cerebrospinal Fluid Protein.

Oncology: Total Prostate Specific Antigen.

Plasma Proteins: C-Reative Protein, CardioPhase High Sensitivity C-Reactive Protein, and Prealbumin.

Reproductive Endocrinology: Beta Human Chronic Gonadotropin, Estradiol, Folicle Stimulating Hormone, Lutenizing Hormone, Progesterone, and Prolactin.

Therapuetic Drug Monitoring: Digoxin, Gentamicin, Lithium, Phenytoin, Valproic Acid, and Vancomycin.

Thyroid Studies: Free Thyroxine, Free Triiodothyroxine, and Thyroid stimulating Hormone.

Toxicology Studies: Acetaminophen, Ethanol, and Salicylate.

The analyzer(s) will have the capabilities of: priority run interruptions, STAT 30 minute turnaround time, performing linearity, precision and verification studies, onboard sample aliquots which can be used for add on tests, over range dilutions, reruns, reflex testing and panic repeats without operator intervention, pediatric (micro samples) low volume capabilities, minimum throughput of 200 samples/hour and 1000 tests/hour.

The contractor will complete all correlation, precision, linearity, normal range, initial training of personnel and any other required validation studies when the instruments are installed.

2.2. The Contractor shall supply all reagents, consumables, calibrators and supplies required when ordered by the Government. The supply level ordered and provided will be based on the needs of the institution.

Calibration intervals will be specifically matched to testing performed by each Government institution. Orders are placed by the Government on an as-needed basis.

2.2.1. Reagents:

2.2.1.1. All reagents should be “ready-to-use” and require no user performed reagent preparation for any standard testing method.

2.2.1.2. Reagents must have a bar-code identification containing the lot number, expiration date, and unique identification code.

2.2.1.3. Bulk deliveries of reagents shall contain the same lot number for each analyte delivered.

2.2.1.4. Reagent kits must contain all calibrators necessary to calibrate each analyte lot.

2.2.1.5. Reagents and consumables will be shipped to:

673 MDSS/SGSL

5955 Zeamer Avenue

JBER, AK 99506

2.3. The Contractor will provide written procedures for Government personnel to perform daily and weekly maintenance procedures that facilitate and maintain routine day-to-day operations.

Monthly maintenance will be conducted by the contractor.

2.4. The Contractor will provide two hard copies of the manufacturer’s manual(s) for use in the event that the automated management system is non-functional.

2.5. If the analyzer(s) incorporates a water system for operation, the Contractor will provide the de-ionized water supply equipment, hardware and connection items to support proper operation of the analyzer(s) including maintenance.

2.6. The Government will provide:

2.6.1. An adequate work environment to include proper heat, light, ventilation, and electrical outlets for use by the analyzer(s) and personnel when servicing the equipment.

2.6.2. A laboratory coat and gloves when the personnel are working in a potentially infectious area of the laboratory.

SECTION 3

GENERAL INFORMATION

3. Training: The Contractor will provide training of Government personnel as required for proper operation of the analyzer. If training is off-site, airfare, lodging, meals, and local transportation are at the Contractor’s expense. The Contractor shall not be responsible for any negligence of the Government, its officers, agent, servants and employees who have been adequately trained with regard to any claims, loss, damage, injury and liability resulting from the use of the Contractor’s analyzer. Due to the high turn-over rate of military staff, the Contractor will provide Government personnel training as follows:

673d Medical Group will be allotted 2 training slots per year in the first ordering year of the contract, then 2 additional training slot for each consecutive ordering year, up to 4 years for a total contract period of 5 years.

3.1. Service and/or Maintenance Agreement:

3.1.1. The service and/or maintenance agreement shall provide for maintenance of the analyzers in a manner that is equivalent to the industry standard and will ensure optimum operation of the analyzers. This shall include preventive and emergency service. The Contractor shall respond to emergency service calls within one (1) hour by phone, and if required, arrive on-site within 24 hours or at a mutually agreed upon time.

3.1.2. The Contractor shall provide 24/7 telephone access to a troubleshooting service.

3.1.3. The Contractor shall coordinate preventive maintenance scheduling through the Government institution as necessary. To schedule call 673d Medical Group Lab Phone at (907) 580-6552. Routine or preventive maintenance will be scheduled during daytime business hours, Monday through Friday, between 0700 AM and 1600 PM Alaska Time. Emergency service can be coordinated outside of normal business hours. No preventive maintenance or consumable deliveries shall be made on Saturdays, Sundays, federal holidays, or military family days. A schedule can be provided each contract year. If weather conditions exist that prevent a service technician from responding within 24 hours for on-site repairs, Clinical Laboratory staff must be notified within 2 hours of the scheduled time the service technician is to arrive.

3.1.4. If on-site service is required, the Contractor shall arrive on-site within: 24-hours from the time of the service call if the analyzer is inoperable; within 48-hours if the analyzer is operating, but with difficulty; and within 3 work days, if the system is exhibiting minor problems which do not inhibit analyzer operation or patient result quality.

3.1.5. The Contractor shall be responsible for cleanup of any and all areas where maintenance has been performed.

3.1.6. The Contractor shall furnish all software upgrades at no additional cost to the Government.

3.1.7. All non-consumable parts and service for the analyzer are the responsibility of the Contractor. Any parts removed or replaced from the equipment shall remain property of the Contractor. After receipt of replacement parts, the Government shall return all defective parts as instructed by the Contractor via surface carrier. Shipping expense of all parts is the responsibility of the Contractor.

3.1.8. The Contractor shall not be responsible for malfunctions as the result of: wear and tear due to non-performance of routine operator maintenance and cleaning or external damage caused by the Government to any piece of equipment.

3.1.9. All Contractor employees must check in and check out within the standard operating procedures for each Government institution. Any Contractor visits for maintenance and repairs for the 673d Medical Group analyzers must be coordinated with each the Biomedical Equipment Repair Technician (BMET) office at (907)580-6397. All equipment must be returned to fully operational condition before a laboratory technician accepts the work. The laboratory technician will inspect the work for completion and sign a work order prior to the service repair technician’s departure. Immediately following each preventive maintenance or repair visit, the Contractor’s service technician will submit a written report to the BMET office explaining the repairs and/or maintenance performed.

3.2. Records

3.2.1. In the event of any changes or revision in test methodology, the Contractor shall provide such changes in writing to the Government within five (5) days after publication of changes.

3.2.2. The Contractor shall be responsible for creating, maintaining, and disposing of only those records specifically required by provisions of mandatory directives, specifically but not limited to those identified by the College of American Pathologists (CAP) accreditation guidelines.

3.2.3. If requested by the Government, the Contractor will provide the original record, or a reproducible copy of any such record within two (2) working days of receipt of the request.

3.3. Contractor Personnel

3.3.1. The Contractor shall provide a point of contact (POC) that shall be responsible for the performance of service work on the analyzers. The Contractor shall designate this individual, in writing, and provide contact information to the Government before the contract start date. An alternate POC may be designated, but the Contractor must identify those times when the alternate shall be the primary POC. The Contractor’s POC must be able to read, write, speak, and understand English fluently.

3.3.2. The Contractor shall obtain all necessary licenses and/or permits required to perform his/her work on the analyzer as identified by the analyzer’s manufacturer.

3.3.3. The Contractor shall take all reasonable precaution necessary to protect persons and property from injury or damage during the performance of this contract.

3.3.4. The Contractor shall not employ persons for work on this contract if the employee is identified to the Contractor by the Contracting Officer as a potential threat to the health, safety, security, general well-being or operational mission of the installation and its population.

3.3.5. Contractor personnel shall present a professional appearance and be easily recognized as Contractor employees. Contractor personnel shall abide by all installation traffic laws, rules and regulations.

3.3.6. Contractor employees that perform equipment repairs and preventive maintenance on the analyzer are required to be company trained prior to starting work under the conditions of this agreement.

3.4. Licensing and Certification: The Contractor shall provide evidence of reapplication for any state license, Clinical Laboratory Improvement Amendments (CLIA) certification, or clinical pathology certifications such as those issued by CAP to the Government within 60 days prior to license expiration. The Contractor shall provide a copy of the renewed licenses or certificates to the Government prior to expiration.

3.5. Security

3.5.1. The Contractor shall ensure all personnel employed in the performance of this contract, or any representative of the Contractor entering the Government installation, abides by all applicable security regulations (AFI 31-204, Air Force Motor Vehicle Traffic Supervision, Chapters 2 & 3).

Attachment 4

AutoCAD SHX Text J

AutoCAD SHX Text J

AutoCAD SHX Text R6200

AutoCAD SHX Text L2250

AutoCAD SHX Text R6080

AutoCAD SHX Text R7100

AutoCAD SHX Text R7100

AutoCAD SHX Text R7100

AutoCAD SHX Text

PNEUMATIC TUBE

AutoCAD SHX Text E

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text E

AutoCAD SHX Text E

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text E

AutoCAD SHX Text J

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text J

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text E

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text

'1LED'-

AutoCAD SHX Text 1,3

AutoCAD SHX Text

'1LED'-12,14,16

AutoCAD SHX Text J

AutoCAD SHX Text J

AutoCAD SHX Text J

AutoCAD SHX Text J

AutoCAD SHX Text J

AutoCAD SHX Text J

AutoCAD SHX Text J

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text

'1LED'- 13,15,17

AutoCAD SHX Text

'1LDD'-9,11

AutoCAD SHX Text

'1LEJ'-25,27,29

AutoCAD SHX Text

'1LNG'-6,8,10

AutoCAD SHX Text J

AutoCAD SHX Text

'1LEJ'-20,22,24

AutoCAD SHX Text

'1LNG'-6,8,10

AutoCAD SHX Text J

AutoCAD SHX Text

'1LED'-

AutoCAD SHX Text 32,34

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text E

AutoCAD SHX Text E

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text E

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text E

AutoCAD SHX Text E

AutoCAD SHX Text E

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text J

AutoCAD SHX Text

'1LDG'-11

AutoCAD SHX Text

'1LNG'-13,15,17

AutoCAD SHX Text

'1LDD'-12

AutoCAD SHX Text

'1LEM'-7,9,11

AutoCAD SHX Text

'1LNG'-13,15,17

AutoCAD SHX Text

'1LDD'10

AutoCAD SHX Text

'1LEM'-8,10,12

AutoCAD SHX Text

'1LEJ'-

AutoCAD SHX Text 26,28,30

AutoCAD SHX Text

'1LDD'-7

AutoCAD SHX Text

'1LNG'-

AutoCAD SHX Text 6,8,10

AutoCAD SHX Text 13,15,17

AutoCAD SHX Text

'1LEM'-

AutoCAD SHX Text

'1LEM'-

AutoCAD SHX Text 14,16,18

AutoCAD SHX Text

'1LDD'-11

AutoCAD SHX Text

'1LEJ'-

AutoCAD SHX Text 20,22,24

AutoCAD SHX Text

'1LNG'-

AutoCAD SHX Text 6,8,10

AutoCAD SHX Text

'1LDD'-11

AutoCAD SHX Text

'1LNG'-12,14,16

AutoCAD SHX Text

'1LDD'-13

AutoCAD SHX Text

'1LEM'-19,21,23

AutoCAD SHX Text R7100

AutoCAD SHX Text

CLINICAL

AutoCAD SHX Text

PATHOLOGY

AutoCAD SHX Text 1F105

AutoCAD SHX Text J

AutoCAD SHX Text J

AutoCAD SHX Text

'1LEM'-

AutoCAD SHX Text

AutoCAD SHX Text D

AutoCAD SHX Text 1C112